Coagulase Test: Slide and Tube Methods for Staphylococcus Identification

The coagulase test is a fundamental microbiological procedure used to differentiate Staphylococcus aureus from other staphylococcal species based on the bacterium's ability to produce coagulase enzymes that convert fibrinogen to fibrin, causing plasma to clot. This test is essential for preliminary identification in clinical, food safety, and research laboratories because S. aureus is a significant human pathogen, while coagulase-negative staphylococci (CoNS) are typically less virulent or are contaminants. The test exists in two principal formats: the slide coagulase test, which detects bound coagulase (clumping factor) on the bacterial cell surface, and the tube coagulase test, which detects free coagulase secreted into the surrounding medium. Both methods are used together to maximize diagnostic accuracy, as some S. aureus strains may be negative in one format but positive in the other.

At a Glance

Scientific Principle

The coagulase test relies on the enzymatic conversion of fibrinogen to fibrin by staphylococcal coagulase enzymes. Staphylococcus aureus produces two distinct forms of coagulase that are detected by different test methods.

Bound coagulase (clumping factor) is an enzyme covalently attached to the bacterial cell wall. It directly binds to fibrinogen in plasma, causing fibrinogen molecules to cross-link and form a visible clump of bacterial cells. This reaction occurs within seconds and is the basis of the slide coagulase test. The clumping factor is considered a virulence factor because it promotes bacterial aggregation and resistance to phagocytosis.

Free coagulase (staphylocoagulase) is a secreted enzyme that reacts with a plasma component called coagulase-reacting factor (CRF), which is prothrombin. The staphylocoagulase-CRF complex converts fibrinogen to fibrin, forming a visible clot in liquid plasma. This reaction takes longer (1–4 hours) and is detected in the tube coagulase test. Free coagulase is encoded by the coa gene, and genetic variation in this gene can affect test results.

The distinction between these two forms is clinically important. Research has shown that some S. aureus strains with certain staphylocoagulase genotypes may test negative in the tube coagulase test while remaining positive in the slide test [1]. In a study of 122 clinical bloodstream S. aureus isolates, 18.9% tested negative in the tube coagulase test, yet all but one were positive in the slide test [1]. This finding underscores the importance of performing both tests for accurate identification.

Materials and Instrumentation Choices

Plasma Selection

The choice of plasma is critical for test reliability. Rabbit plasma is the standard reagent for both slide and tube coagulase tests because it provides consistent results with minimal interference. Human plasma may be used but is less standardized and carries biosafety risks. The plasma must be free of anticoagulants other than sodium citrate (3.8% or 3.2%), as EDTA or heparin can inhibit the coagulase reaction.

For the slide coagulase test, undiluted or minimally diluted rabbit plasma is used. Commercial preparations are available as lyophilized plasma that is reconstituted according to the manufacturer's instructions. For the tube coagulase test, plasma is typically diluted 1:5 or 1:10 in sterile saline or phosphate-buffered saline to provide sufficient volume for clot formation and to prevent false-negative results from excess fibrinogen.

Bacterial Culture Requirements

The test requires a pure, fresh (18–24 hour) bacterial culture grown on non-selective solid media such as tryptic soy agar (TSA) or blood agar. Cultures older than 24 hours may have reduced coagulase activity, leading to false-negative results. The culture should be well-isolated to ensure a single colony type is tested.

Equipment

• Clean glass microscope slides (for slide test)
• Sterile inoculating loops or wooden sticks
• Sterile test tubes (13 × 100 mm or similar) for tube test
• Incubator set at 35–37°C
• Timer or clock
• Saline (0.85% NaCl) for suspension preparation
• Positive and negative control strains

Controls

Controls are essential for validating test performance and interpreting results. Both positive and negative controls must be included with each batch of tests.

Positive Control

Use a known Staphylococcus aureus strain (e.g., ATCC 25923) that is positive for both bound and free coagulase. This control confirms that the plasma is active and the test reagents are functioning correctly. The positive control should produce a visible clump within 10–30 seconds in the slide test and a firm clot within 4 hours in the tube test.

Negative Control

Use a known coagulase-negative staphylococcus (CoNS) such as Staphylococcus epidermidis (e.g., ATCC 12228). This control should show no clumping in the slide test and no clot formation in the tube test. The negative control also helps detect auto-agglutination problems.

Saline Control (Slide Test)

For the slide test, a separate suspension of the test organism in saline (without plasma) should be examined for auto-agglutination. If the organism clumps in saline alone, the slide coagulase test is invalid, and only the tube test should be used for identification.

Conceptual Workflow

Slide Coagulase Test Procedure

1. Place a drop of saline (approximately 20–30 µL) on a clean glass slide.
2. Using a sterile inoculating loop, emulsify a small portion of a single colony from an 18–24 hour culture into the saline to create a smooth, milky suspension. The suspension should be homogeneous without visible clumps.
3. Add one drop of rabbit plasma to the suspension and mix gently with the loop.
4. Rock the slide gently for 10–30 seconds and observe for clumping.
5. A positive result is the formation of visible clumps within 30 seconds. Any clumping after 30 seconds is considered delayed and may be due to free coagulase; confirm with the tube test.
6. Record the result as positive, negative, or invalid (if auto-agglutination occurs).

Tube Coagulase Test Procedure

1. Prepare a 1:5 or 1:10 dilution of rabbit plasma in sterile saline (e.g., 0.2 mL plasma + 0.8 mL saline for 1:5 dilution).
2. Dispense 0.5 mL of diluted plasma into a sterile test tube.
3. Using a sterile loop, inoculate the plasma with 3–4 well-isolated colonies from an 18–24 hour culture. Emulsify the colonies against the tube wall to ensure good mixing.
4. Incubate the tube at 35–37°C in ambient air.
5. Examine the tube at 1, 2, 4, and 24 hours for clot formation. Gently tilt the tube to check for a clot; do not shake vigorously.
6. A positive result is any visible clot (from a loose web-like clot to a firm clot that does not move when the tube is tilted).
7. Record the time of clot formation and the degree of clotting (e.g., 1+ for small loose clot, 2+ for moderate clot, 3+ for firm clot, 4+ for solid clot).

Quality Checks

Plasma Activity Verification

Before using a new lot of rabbit plasma, verify its activity by testing with known positive and negative control strains. Plasma that fails to produce a positive result with the positive control within 4 hours should be discarded.

Culture Purity

Always examine the culture for purity before testing. Mixed cultures can produce ambiguous results. If the culture appears mixed, re-streak for isolation and test a single colony.

Timing Consistency

For the slide test, results must be read within 30 seconds. Delayed clumping (after 30 seconds) may be caused by free coagulase in the suspension and should be confirmed with the tube test. For the tube test, examine at the specified intervals; a clot that forms only after 24 hours may be due to other factors and should be interpreted cautiously.

Reagent Storage

Reconstituted plasma should be stored at 2–8°C and used within the manufacturer's specified timeframe. Do not freeze reconstituted plasma unless the manufacturer indicates it is stable. Discard plasma that appears turbid or contains visible particles.

Result Interpretation

Slide Coagulase Test

A positive slide test strongly suggests S. aureus, but confirmation with the tube test is recommended because some S. aureus strains may lack clumping factor, and some other staphylococci (e.g., S. lugdunensis) can produce clumping factor.

Tube Coagulase Test

A positive tube test confirms S. aureus identification. However, as noted in recent research, up to 18.9% of S. aureus isolates may test negative in the tube test due to specific staphylocoagulase genotypes [1]. Therefore, a negative tube test does not rule out S. aureus if the slide test is positive.

Combined Interpretation

Troubleshooting

Limitations

False Positives

The slide coagulase test can produce false-positive results due to auto-agglutination of certain bacterial strains. Some non-staphylococcal organisms, such as Macrococcus caseolyticus and Mammaliicoccus fleurettii (formerly Staphylococcus fleurettii), have been shown to produce false-positive results in agglutination-based identification tests [3]. In a study of meat samples, 8 of 30 isolates positive in the SlidexStaph agglutination test were identified as M. caseolyticus, and 4 as M. fleurettii [3]. This highlights the need for confirmatory testing, especially in food safety applications.

False Negatives

The tube coagulase test may miss S. aureus strains with certain staphylocoagulase genotypes. Research has demonstrated that 18.9% of clinical S. aureus isolates tested negative in the tube coagulase test, despite all isolates possessing the coa gene [1]. This limitation is particularly relevant in clinical settings where accurate identification is critical for patient management.

Strain Variability

Different S. aureus strains may produce varying amounts of coagulase. Methicillin-resistant S. aureus (MRSA) isolates have been shown to have faster and stronger tube coagulase test results compared to methicillin-sensitive S. aureus (MSSA) isolates [2]. This variability means that test timing and interpretation must account for strain differences.

Plasma Source Variability

The source and preparation of plasma can affect test results. Rabbit plasma is preferred, but even within rabbit plasma, lot-to-lot variation can occur. Commercial preparations should be used according to manufacturer instructions, and each new lot should be validated with control strains.

Documentation

Record Keeping

For each coagulase test performed, document the following information in the laboratory notebook or electronic laboratory record:

• Date and time of test
• Sample identification (source, collection date, accession number)
• Culture age and medium used
• Plasma lot number and expiration date
• Control strains used and their results
• Slide test result (positive, negative, invalid) with time to clumping
• Tube test result (positive, negative) with time to clot formation and degree of clotting
• Any observations (e.g., auto-agglutination, delayed reaction)
• Interpretation and follow-up actions

Reporting Results

Results should be reported as:

• Slide coagulase positive: "Bound coagulase detected (clumping factor positive)"
• Slide coagulase negative: "Bound coagulase not detected"
• Tube coagulase positive: "Free coagulase detected (coagulase positive)"
• Tube coagulase negative: "Free coagulase not detected"
• Combined interpretation: "Presumptive Staphylococcus aureus" or "Coagulase-negative staphylococcus (CoNS)" as appropriate

Quality Control Records

Maintain records of all quality control tests, including:

• Date of control testing
• Control strains used (with ATCC numbers)
• Plasma lot numbers
• Results (positive and negative controls)
• Any corrective actions taken

Biosafety Considerations

Risk Assessment

The coagulase test is typically performed with bacterial cultures that are handled at Biosafety Level 2 (BSL-2) in clinical and research laboratories. Staphylococcus aureus is a human pathogen capable of causing a range of infections, from skin infections to life-threatening bacteremia. Standard microbiological practices, as outlined in the Biosafety in Microbiological and Biomedical Laboratories (BMBL) 6th Edition, should be followed [6].

Personal Protective Equipment (PPE)

• Laboratory coat or gown
• Gloves (nitrile or latex)
• Safety glasses or face shield (when splashing is possible)
• Closed-toe shoes

Work Practices

• Perform all manipulations in a biological safety cabinet (BSC) when working with liquid cultures or when aerosol generation is possible.
• Use proper aseptic technique to avoid contamination of reagents and cultures.
• Decontaminate work surfaces before and after procedures with an appropriate disinfectant (e.g., 10% bleach or 70% ethanol).
• Dispose of all contaminated materials (slides, tubes, loops) in biohazard waste containers.
• Wash hands thoroughly after removing gloves and before leaving the laboratory.

Waste Disposal

• Solid waste (slides, tubes, loops) should be autoclaved before disposal.
• Liquid waste (plasma, bacterial suspensions) should be treated with an appropriate disinfectant or autoclaved.
• Follow institutional guidelines for biohazard waste disposal.

Special Considerations for MRSA

Methicillin-resistant Staphylococcus aureus (MRSA) requires the same BSL-2 containment as MSSA but may warrant additional precautions due to its antibiotic resistance profile. MRSA is responsible for over 70,000 severe human infections and 9,000 deaths per year in the United States [4]. Enhanced hand hygiene and environmental cleaning are recommended when working with MRSA isolates.

Frequently Asked Questions

1. Why would a Staphylococcus aureus isolate be positive in the slide coagulase test but negative in the tube coagulase test?

This occurs because the two tests detect different forms of coagulase. The slide test detects bound coagulase (clumping factor) on the bacterial cell surface, while the tube test detects free coagulase secreted into the medium. Some S. aureus strains possess the coa gene encoding free coagulase but produce a variant form that is not detected by the standard tube test. Research has shown that 18.9% of clinical S. aureus isolates may test negative in the tube test while remaining positive in the slide test [1]. In such cases, the isolate should still be reported as presumptive S. aureus, and confirmatory testing (e.g., PCR for the coa gene or MALDI-TOF MS) should be performed.

2. Can the coagulase test be used to differentiate Staphylococcus aureus from other staphylococci in food samples?

The coagulase test is a useful screening tool for S. aureus in food samples, but it has limitations. False-positive results can occur with other bacteria that produce coagulase or cross-react in agglutination tests. For example, Macrococcus caseolyticus and Mammaliicoccus fleurettii have been shown to produce false-positive results in agglutination-based identification tests [3]. In food safety applications, positive coagulase test results should be confirmed with additional methods such as MALDI-TOF MS or species-specific PCR to avoid misidentification.

3. How long should I incubate the tube coagulase test before reporting a negative result?

The standard incubation time for the tube coagulase test is 4 hours at 35–37°C. If no clot is observed at 4 hours, the tube should be re-examined at 24 hours before reporting a negative result. Some S. aureus strains produce free coagulase slowly and may only form a clot after extended incubation. However, a clot that appears only after 24 hours should be interpreted cautiously, as other factors (e.g., bacterial growth or plasma degradation) can cause false-positive results. If a clot appears only at 24 hours, confirm the result with additional tests such as the slide coagulase test or molecular methods.

4. What should I do if my test organism auto-agglutinates in the saline control for the slide coagulase test?

Auto-agglutination in the saline control indicates that the slide coagulase test is invalid for that particular isolate. This can occur with certain bacterial strains that have sticky cell surfaces or produce extracellular polysaccharides. In such cases, do not report a slide coagulase result. Instead, proceed directly to the tube coagulase test, which is not affected by auto-agglutination. If the tube test is also negative, consider using alternative identification methods such as the catalase test, DNAse test, or molecular techniques to confirm the organism's identity.

References and Further Reading

1. Staphylococcus aureus Strains With a Negative Coagulase Tube Test are Associated With Staphylocoagulase Genotypes
2. Enhanced platelets aggregation and coagulation of methicillin-resistant Staphylococcus aureus compared to methicillin-sensitive Staphylococcus aureus
3. False positive results obtained with latex agglutination identification of Staphylococcus aureus caused by Macrococcus caseolyticus and Mammaliicoccus fleurettii
4. Prevalence and risk factors of methicillin-resistant Staphylococcus aureus in raw cow's milk and nasal and hand swabs of milkers in dairy farms in Mekelle city, Northern Ethiopia
5. Prevalence, Antimicrobial Resistance, and Molecular Characteristics of MRSA in Saudi Arabia: A Retrospective Study
6. Biosafety in Microbiological and Biomedical Laboratories (BMBL), 6th Edition
7. NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules
8. NCBI Bookshelf: Molecular Biology and Laboratory Methods

Related Articles

• Novobiocin Susceptibility Test for Staphylococcus saprophyticus Identification
• Biochemical Test Comparison: Catalase, Oxidase, and Coagulase for Bacterial Identification
• Optochin Susceptibility Test for Streptococcus pneumoniae Identification
• Bacitracin Susceptibility Test for Group A Streptococcus Identification
• How to Perform a CAMP Test: Principle and Protocol
• How to Perform a PYR Test: Principle and Protocol